NCM · Financial Statements

Nexalin Technology, Inc. (NXL) Financial Statements

$3.63 NCM: NXL Market Cap $2.66M

Nexalin Technology, Inc. most recently reported annual revenue of $0, net profit of $-8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$0$0$0
Operating Profit$-6.0M$-2.0M$-6.0M$-8.0M$-8.0M
Net Profit$-6.0M$-2.0M$-5.0M$-8.0M$-8.0M
EPS$-24.90$-6.90$-18.90$-24.90$-15.00
Op Margin-4177.7%-138.7%-5143.5%-4596.1%-2781.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$7.0M$4.0M$4.0M$5.0M
Total Liabilities$2.0M$2.0M$0$1.0M$1.0M
Cash$1.0M$0$1.0M$1.0M$1.0M
Borrowings$1.0M$1.0M$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-2.0M$-4.0M$-4.0M$-5.0M
Investing Cash Flow$0$-7.0M$4.0M$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$0$0$0$0
Free Cash Flow$-1.0M$-2.0M$-4.0M$-4.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.36
FCF Yield-147.75%
Quick Ratio1.10
Interest Coverage0.00
Return 1Y-54.02%
Return 3Y-42.45%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
NXL Overview NXL Dividend Run Stock Screener